Stichting Centre for Human Drug Research (CHDR)
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1987-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.chdr.nl
Clinical Trials
202
Active:34
Completed:123
Trial Phases
4 Phases
Phase 1:33
Phase 2:7
Phase 4:8
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (60 trials with phase data)• Click on a phase to view related trials
Phase 1
33 (55.0%)Not Applicable
12 (20.0%)Phase 4
8 (13.3%)Phase 2
7 (11.7%)No trials found
News
Immutep's IMP761 Shows 80% T Cell Suppression in Phase I Autoimmune Disease Trial
Immutep's first-in-class LAG-3 agonist antibody IMP761 demonstrated 80% inhibition of T cell infiltration at 0.9 mg/kg dose with no treatment-related adverse events in healthy participants.